Our Origgio site forms the heart of Archimica’s cGMP capability and has been manufacturing APIs since the 1970s. Origgio is the center of our global regulatory compliance effort and has been the subject of continuing investment to maintain state-of-the-art conditions.

Origgio excels in multipurpose facilities permitting flexible production of bulk APIs and late-stage intermediates. It comprises cGMP production facilities, pilot plants, R&D, QC, and microbiology laboratories. The site fully complys with ICH Q7A regulations and is FDA-inspected. Origgio is authorized by the Italian Ministry of Health for the production of human and veterinary drugs.